Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 824605, 10 pages
http://dx.doi.org/10.1155/2013/824605
Research Article

Effect of Korean Herbal Medicine Combined with a Probiotic Mixture on Diarrhea-Dominant Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo-Controlled Trial

1College of Korean Medicine, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 130-701, Republic of Korea
2Cell Biotech, Co., Ltd., Gaegok-Ri, Wolgot-myeon, Gyeonggi-do, Gimpo-si 415-871, Republic of Korea
3College of Sookmyung Women’s University, Cheongpa-dong 2-ga, Yongsan-gu, Seoul 140-742, Republic of Korea
4Kangnam Korean Hospital, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 130-701, Republic of Korea

Received 18 April 2013; Revised 4 November 2013; Accepted 15 November 2013

Academic Editor: Kenji Watanabe

Copyright © 2013 Seok-Jae Ko et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. F. Longstreth, W. G. Thompson, W. D. Chey, L. A. Houghton, F. Mearin, and R. C. Spiller, “Functional bowel disorders,” Gastroenterology, vol. 130, no. 5, pp. 1480–1491, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Y. Chang, “The current prevalence of irritable bowel syndrome in Asia,” Journal of Neurogastroenterology and Motility, vol. 16, no. 4, pp. 389–400, 2010. View at Publisher · View at Google Scholar
  3. M. Duracinsky and O. Chassany, “How can an effective drug to treat irritable bowel syndrome be successfully developed?” Gastroenterologie Clinique et Biologique, vol. 33, no. 1, pp. S26–S34, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Rajilić-Stojanović, E. Biagi, H. G. H. J. Heilig et al., “Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome,” Gastroenterology, vol. 141, no. 5, pp. 1792–1801, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. S. P. Dunlop, J. Hebden, E. Campbell et al., “Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes,” American Journal of Gastroenterology, vol. 101, no. 6, pp. 1288–1294, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. J. C. Y. Wu, “Complementary and alternative medicine modalities for the treatment of irritable bowel syndrome: facts or myths?” Gastroenterology and Hepatology, vol. 6, no. 11, pp. 705–711, 2010. View at Google Scholar · View at Scopus
  7. Y. B. Kim, J. H. Kim, and B. Y. Chae, “Effects on Koakhyangieonggisan and Gamikoahyangieonggisan on the digestive and anti-allergic function,” Journal of Korean Medical Society, vol. 10, pp. 11–23, 1993. View at Google Scholar
  8. K. W. Ryu, B. H. Ryu, H. S. Yun, and D. W. Park, “Experimental comparative studies on the effects of Kwakhyangjeonggisan and Souminkwakhyang-jeonggisan,” Journal of Korean Medical College of KyungHee University, vol. 21, 1998. View at Google Scholar
  9. J. H. Han, G. B. Kim, I. S. Han, Y. S. Shim, and E. G. Kim, “A clinical report of chronic diarrhea treated with GwakHyang-JungGiSan,” Journal of Korean Internal Medicine, vol. 26, pp. 889–896, 2005. View at Google Scholar
  10. J. P. Liu, M. Yang, Y. X. Liu, M. L. Wei, and S. Grimsgaard, “Herbal medicines for treatment of irritable bowel syndrome,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD004116, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. B. K. Cha, S. M. Jung, C. H. Choi et al., “The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial,” Journal of Clinical Gastroenterology, vol. 46, no. 3, pp. 220–227, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. “Herbal formula and lactic acid bacteria,” http://www.akomnews.com/subpage/search_detail.php?code =A001&uid=53825&page=/subpage/search.php&nowpage=1&search_word.
  13. S.-J. Ko, B. Ryu, J. Kim et al., “Effect of herbal extract granules combined with probiotic mixture on irritable bowel syndrome with diarrhea: study protocol for a randomized controlled trial,” Trials, vol. 12, article 219, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. H. J. Kim, M. Camilleri, S. McKinzie et al., “A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome,” Alimentary Pharmacology and Therapeutics, vol. 17, no. 7, pp. 895–904, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Vejdani, H. R. M. Shalmani, M. Mir-Fattahi et al., “The efficacy of an herbal medicine, Carmint, on the relief of abdominal pain and bloating in patients with irritable bowel syndrome: a pilot study,” Digestive Diseases and Sciences, vol. 51, no. 8, pp. 1501–1507, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. H. J. Kim, M. I. Vazquez Roque, M. Camilleri et al., “A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating,” Neurogastroenterology and Motility, vol. 17, no. 5, pp. 687–696, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. S. J. Lewis and K. W. Heaton, “Stool form scale as a useful guide to intestinal transit time,” Scandinavian Journal of Gastroenterology, vol. 32, no. 9, pp. 920–924, 1997. View at Google Scholar · View at Scopus
  18. B. Coulie, L. A. Szarka, M. Camilleri et al., “Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans,” Gastroenterology, vol. 119, no. 1, pp. 41–50, 2000. View at Google Scholar · View at Scopus
  19. D. A. Drossman, D. L. Patrick, W. E. Whitehead et al., “Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire,” American Journal of Gastroenterology, vol. 95, no. 4, pp. 999–1007, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. J. M. Park, M.-G. Choi, J. H. Oh et al., “Cross-cultural validation of irritable bowel syndrome quality of life in Korea,” Digestive Diseases and Sciences, vol. 51, no. 8, pp. 1478–1484, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. Q. Zhou, B. Zhang, and G. Nicholas Verne, “Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome,” Pain, vol. 146, no. 1-2, pp. 41–46, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Hollander, “Intestinal permeability, leaky gut, and intestinal disorders,” Current Gastroenterology Reports, vol. 1, no. 5, pp. 410–416, 1999. View at Google Scholar · View at Scopus
  23. M. Camilleri and H. Gorman, “Intestinal permeability and irritable bowel syndrome,” Neurogastroenterology and Motility, vol. 19, no. 7, pp. 545–552, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Malinen, L. Krogius-Kurikka, A. Lyra et al., “Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome,” World Journal of Gastroenterology, vol. 16, no. 36, pp. 4532–4540, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Wang and N. Nishino, “Presence of sourdough lactic acid bacteria in commercial total mixed ration silage as revealed by denaturing gradient gel electrophoresis analysis,” Letters in Applied Microbiology, vol. 51, no. 4, pp. 436–442, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Hoveyda, C. Heneghan, K. R. Mahtani, R. Perera, N. Roberts, and P. Glasziou, “A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome,” BMC Gastroenterology, vol. 9, article 15, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Rahimi and M. Abdollahi, “Herbal medicines for the management of irritable bowel syndrome: a comprehensive review,” World Journal of Gastroenterology, vol. 18, no. 7, pp. 589–600, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. W. K. Leung, J. C. Y. Wu, S. M. Liang et al., “Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial,” American Journal of Gastroenterology, vol. 101, no. 7, pp. 1574–1580, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. L. O'Mahony, J. Mccarthy, P. Kelly et al., “Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles,” Gastroenterology, vol. 128, no. 3, pp. 541–551, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Camilleri, “Is there a role for probiotics in irritable bowel syndrome?” Digestive and Liver Disease, vol. 38, no. 2, pp. S266–S269, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Pathmakanthan, C. K. F. Li, J. Cowie, and C. J. Hawkey, “Lactobacillus plantarum 299: beneficial in vitro immunomodulation in cells extracted from inflamed human colon,” Journal of Gastroenterology and Hepatology, vol. 19, no. 2, pp. 166–173, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Ménard, C. Candalh, J. C. Bambou, K. Terpend, N. Cerf-Bensussan, and M. Heyman, “Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport,” Gut, vol. 53, no. 6, pp. 821–828, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. C. M. C. Chapman, G. R. Gibson, and I. Rowland, “Health benefits of probiotics: are mixtures more effective than single strains?” European Journal of Nutrition, vol. 50, no. 1, pp. 1–17, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Enck, K. Zimmermann, G. Menke, S. Müller-Lissner, U. Martens, and S. Klosterhalfen, “A mixture of Escherichia coli (DSM 17252) and Enterococcus faecalis (DSM 16440) for treatment of the irritable bowel syndrome—a randomized controlled trial with primary care physicians,” Neurogastroenterology and Motility, vol. 20, no. 10, pp. 1103–1109, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. P. J. Whorwell, L. Altringer, J. Morel et al., “Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome,” American Journal of Gastroenterology, vol. 101, no. 7, pp. 1581–1590, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Niv, T. Naftali, R. Hallak, and N. Vaisman, “The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome—a double blind, placebo-controlled, randomized study,” Clinical Nutrition, vol. 24, no. 6, pp. 925–931, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. M. A. O'Sullivan and C. A. O'Morain, “Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study,” Digestive and Liver Disease, vol. 32, no. 4, pp. 294–301, 2000. View at Google Scholar · View at Scopus
  38. A. Madisch, G. Holtmann, K. Plein, and J. Hotz, “Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial,” Alimentary Pharmacology and Therapeutics, vol. 19, no. 3, pp. 271–279, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. G. Wang, T.-Q. Li, L. Wang et al., “Tong-xie-ning, a Chinese herbal formula, in treatment of diarrhea-predominant irritable bowel syndrome: a prospective, randomized, double-blind, placebo-controlled trial,” Zhanghua Yixue Zazhi, vol. 119, no. 24, pp. 2114–2119, 2006. View at Google Scholar · View at Scopus
  40. F. Pan, T. Zhang, Y.-H. Zhang, J.-J. Xu, and F.-M. Chen, “Effect of Tongxie Yaofang granule in treating diarrhea-predominate irritable bowel syndrome,” Chinese Journal of Integrative Medicine, vol. 15, no. 3, pp. 216–219, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. J.-M. Si, Y.-C. Yu, Y.-J. Fan, and S.-J. Chen, “Intestinal microecology and quality of life in irritable bowel syndrome patients,” World Journal of Gastroenterology, vol. 10, no. 12, pp. 1802–1805, 2004. View at Google Scholar · View at Scopus
  42. A. Kassinen, L. Krogius-Kurikka, H. Mäkivuokko et al., “The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects,” Gastroenterology, vol. 133, no. 1, pp. 24–33, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. Y.-J. Fan, S.-J. Chen, Y.-C. Yu, J.-M. Si, and B. Liu, “A probiotic treatment containing Lactobacillus, Bifidobacterium and Enterococcus improves IBS symptoms in an open label trial,” Journal of Zhejiang University Science B, vol. 7, no. 12, pp. 987–991, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Rajilić-Stojanović, E. Biagi, H. G. H. J. Heilig et al., “Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome,” Gastroenterology, vol. 141, no. 5, pp. 1792–1801, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. V. di Leo, R. D'Incà, N. Diaz-Granado et al., “Lactulose/mannitol test has high efficacy for excluding organic causes of chronic diarrhea,” American Journal of Gastroenterology, vol. 98, no. 10, pp. 2245–2252, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. Y.-C. Xie and F. Tang, “Experimental study on protecting intestinal barrier function of Huoxiang Zhengqi soft capsule,” Zhongguo Zhong Yao Za Zhi, vol. 29, no. 5, pp. 456–458, 2004. View at Google Scholar · View at Scopus